Furthermore, in the therapy of ferroptosis+NK cells, tumor cells expressed HMGB1 and PD-L1, and a clear regression of tumor volume after ferumol-mediated ferroptosis and NK cell treatment was observed in a prostate cancer mouse model (62). This evidence concerns the gene CD274 and neoplasm.